Results 11 to 20 of about 37,338 (299)
AMH and AMH receptor defects in persistent Müllerian duct syndrome [PDF]
Human Reproduction Update, 2005 Anti-Müllerian hormone (AMH) produced by fetal Sertoli cells is responsible for regression of Müllerian ducts, the anlage for uterus and Fallopian tubes, during male sex differentiation. A member of the transforming growth factor-beta superfamily, AMH signals through two transmembrane receptors, type II which is specific and type I receptors, shared ...
Josso, Nathalie +3 more
openaire +3 more sources
The correlation between AMH assays differs depending on actual AMH levels [PDF]
Human Reproduction Open, 2017 What is the correlation of serum anti-Müllerian hormone (AMH) levels between two frequently used laboratory assays?A considerable difference was found in serum AMH levels measured with the two different assays, particularly for low AMH values.AMH is regarded as being a robust, highly sensitive and specific biomarker for ovarian response and has become ...
Å Magnusson +3 more
openaire +3 more sources
AMH in Males: Effects of Body Size and Composition on Serum AMH Levels
Journal of Clinical Medicine, 2023 Serum concentrations of anti-Müllerian hormone (AMH) have been found to decrease with increasing body mass index (BMI) in many studies. It is not yet clear whether this stems from an adverse effect of adiposity on AMH production, or from dilution due to the greater blood volume that accompanies a larger body size. To investigate a possible hemodilution
Veronika Tandl +11 more
openaire +3 more sources
Anti‐Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? [PDF]
Clinical Endocrinology, 2006 SummaryAnti‐Müllerian hormone (AMH) is a dimeric glycoprotein, a member of the transforming growth factor (TGF) superfamily. It is produced exclusively in the gonads and is involved in the regulation of follicular growth and development. In the ovary AMH is produced by the granulosa cells of early developing follicles and seems to be able to inhibit ...
LA MARCA , Antonio, VOLPE, Annibale
openaire +3 more sources
AMH assessment five or more years after an initially low AMH level
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2021 Anti-Müllerian hormone (AMH) is a biomarker reflecting ovarian reserve. A low AMH level before 39 years may be associated with a risk of menopause between 40 and 45 years. The risk of onset of premature ovarian insufficiency (POI) is, however, poorly documented.
Sarah Desongnis +4 more
openaire +4 more sources
Endocrine Connections, 2023 Congenital adrenal hyperplasia (CAH) is a recessive condition t hat affects the adrenal glands. Despite life-long replacement therapy with glucocorticoids and mineralocorticoids, adult patients with CAH often experience impaired gonadal function.
Trine Holm Johannsen +11 more
doaj +1 more source
Investigate the Correlation of Growth Hormone with the Level of Some Reproductive Hormones and Certain Parameters in a Number of Iraqi-Aging and Younger Women During IVF/ICSI Cycles [PDF]
Kirkuk Journal of Science, 2023 An estimated 12–20% of couples struggle with infertility, which is described as not becoming pregnant after a year of trying. About one-third of these couples are infertile because of female factors, and another third are infertile because of male ...
Tiba kadhim, Lina Salih
doaj +1 more source
Role of AMH in Prediction of Menopause [PDF]
Frontiers in Endocrinology, 2021 Anti-Müllerian Hormone (AMH) is produced by small antral follicles and has evolved over the past three decades as an assumed potential marker of the number of follicles in the human ovaries, also known as ovarian reserve. This quantitative measure, given the gradual decline over time and its non-replenishable feature, could be the dreamed marker for ...
Annelien C. de Kat +2 more
openaire +3 more sources
, 2023 This is the source code for "Active Mechanical Haptics with High-Fidelity Perceptions for Immersive Virtual Reality" to be published on Nature Machine Intelligence. Full Changelog: https://github.com/EMLQ/AMH/commits/v1.
EMLQ
core +1 more source
Evaluation of Ovarian Reserve by Measurement of the Serum Levels of Anti-Mullerian Hormone and Follicle-Stimulating Hormone in Intracytoplasmic Sperm Injection Cycles [PDF]
International Journal of Fertility and Sterility, 2010 Background It is important to evaluate ovarian reserves prior to intracytoplasmic sperm injection (ICSI) treatment. The aim of this study is to determine the accuracy of anti-mullerian hormone (AMH) as a marker for ovarian reserve and to compare it with ...
Roshan Nikbakht +2 more
doaj +1 more source